(Total Views: 408)
Posted On: 07/12/2018 2:00:39 PM
Post# of 75065
To be fair, he didn't say, nor is it, the same as the FDA. Michael Welch, like most, used the common phrase "the Mexican equivalent" of the FDA.
From what's been in the news recently concerning Mexico's path forward concerning CBD infused products, I highly doubt it'll take 8-12 months. That estimation is more in line with completely unknown substances with no clinical data compiled like clinical trials on some new drug (which actually can take a couple of years or more).
Cannabidiol now has a huge and rapidly growing amount of clinical data, and to date that data has shown only HUGE health benefits and absolutely no harmful side effects. That has to be kept in perspective, of course. For instance, vitamin C in high concentrations such as that found in Polar Bear liver, can be lethal.
I've seen nothing to date where even abnormally high doses of CBD would have catastrophic effects, but those attempting to slow the progression to market continue to express "concerns". Tylenol, aspirin, ibuprofen, YES to all three.
I don't think it'll take them long at all to get the stamp of approval once the contents of each product to be imported have been verified in a COFEPRIS (the Mexican equivalent to the U.S. FDA) run or commissioned laboratory.
The yet to be announced parent company of CBD ALIMENTOS most likely has pull and can expedite the process where there are no "questionable" ingredients.
Remember, the Mexican government had already approved free distribution of non-THC containing CBD products, so there's no clinical question about the safety of Cannabidiol where COFEPRIS is concerned, only the actual verification of the complete list of ingredients in the samples of the products to be imported, and that they are all on their list of approved substances and in normal or safe levels.
There's a major difference between that and clinical trials on some new drug candidate. Of course, we'll just have to wait and see, but it shouldn't take long IMHO.
From what's been in the news recently concerning Mexico's path forward concerning CBD infused products, I highly doubt it'll take 8-12 months. That estimation is more in line with completely unknown substances with no clinical data compiled like clinical trials on some new drug (which actually can take a couple of years or more).
Cannabidiol now has a huge and rapidly growing amount of clinical data, and to date that data has shown only HUGE health benefits and absolutely no harmful side effects. That has to be kept in perspective, of course. For instance, vitamin C in high concentrations such as that found in Polar Bear liver, can be lethal.
I've seen nothing to date where even abnormally high doses of CBD would have catastrophic effects, but those attempting to slow the progression to market continue to express "concerns". Tylenol, aspirin, ibuprofen, YES to all three.
I don't think it'll take them long at all to get the stamp of approval once the contents of each product to be imported have been verified in a COFEPRIS (the Mexican equivalent to the U.S. FDA) run or commissioned laboratory.
The yet to be announced parent company of CBD ALIMENTOS most likely has pull and can expedite the process where there are no "questionable" ingredients.
Remember, the Mexican government had already approved free distribution of non-THC containing CBD products, so there's no clinical question about the safety of Cannabidiol where COFEPRIS is concerned, only the actual verification of the complete list of ingredients in the samples of the products to be imported, and that they are all on their list of approved substances and in normal or safe levels.
There's a major difference between that and clinical trials on some new drug candidate. Of course, we'll just have to wait and see, but it shouldn't take long IMHO.
(7)
(0)Scroll down for more posts ▼
